Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

fool.com - Motley Fool Transcribing - Innate Pharma (IPHA) Q2 2026 Earnings Call Transcript
Innate Pharma (IPHA) Q2 2026 Earnings Call Transcript
The Motley Fool

Thursday, Sept. 17, 2026, at 8 a.m. ET Chief Executive Officer-Jonathan E. Dickinson Chief Medical Officer-Sonia Quaratino Chief Operating Officer-Yannis Morel Chief Financial Officer-Frederic Lombard Vice President of Investor Relations…

news-medical.net - Diaceutics launches Precision for All Strategic Collaboration at Fierce Pharma Week 2026
Diaceutics launches Precision for All Strategic Collaboration at Fierce Pharma Week 2026
News-Medical

Intelligence and engagement company, Diaceutics, is bringing together senior voices from across the biopharmaceutical industry at the Precision for All Strategic Collaboration, launching at Fierce Pharma Week 2026. The initiative will begin with an…

globes.co.il - David Adler - Could Palestinian pharma companies supply Israel? Time to test it
Could Palestinian pharma companies supply Israel? Time to test it
גלובס

More than three decades ago, the Oslo framework identified pharmaceuticals as one area for Israeli-Palestinian industrial cooperation. That idea is worth revisiting today, not because economic cooperation can resolve the Israeli-Palestinian…

marketbeat.com - Innate Pharma Q2 Earnings Call Highlights
Innate Pharma Q2 Earnings Call Highlights
MarketBeat

Innate Pharma NASDAQ: IPHA said its first-half 2026 developments included the closing of a strategic partnership with Sobi for lacutamab, completion of dose-escalation enrollment for IPH4502, and completed enrollment in the PACIFIC-9 phase III…

fool.com - Adria Cimino - This Trend is Excellent News for Eli Lilly and Its Investors
This Trend is Excellent News for Eli Lilly and Its Investors
The Motley Fool

Eli Lilly (LLY +0.15%) is the global leader in one of the hottest growth markets on the planet: the weight loss drug market. The pharma giant holds 60% of the U.S. market, while its closest rival, Novo Nordisk (NVO -1.93%), has about 38% share.

thestandard.com.hk - The Standard 英文虎報 - Cathay Pacific, HK Express carry a record of more than 3.6 million passengers in Aug
Cathay Pacific, HK Express carry a record of more than 3.6 million passengers in Aug
The Standard

Cathay Pacific and budget airline HK Express carried a record number of over 3.6 million passengers in August despite elevated jet fuel prices, driven by robust travel demand during the summer peak. SCROLL TO CONTINUE WITH CONTENT Flagship carrier…

cnbc.com - Joshua Brown - There's a biotech stock on Josh Brown's list that's ignoring the market noise and pushing higher
There's a biotech stock on Josh Brown's list that's ignoring the market noise and pushing higher
CNBC

(This is The Best Stocks in the Market, brought to you by Josh Brown and Sean Russo of Ritholtz Wealth Management.) Josh — Ladies and gentlemen, we interrupt this moment of existential threats from advanced AI models and Federal Reserve…

thehindubusinessline.com - Markets steady after Fed rate hike; mixed trend across indices
Markets steady after Fed rate hike; mixed trend across indices
BusinessLine

Markets held their ground Thursday even as the U.S. Federal Reserve delivered its first interest-rate increase since 2023, raising borrowing costs by 25 basis points and signalling at least one more hike this year, a move that rattled currencies…

forbes.com - Siva Samy - Technology Transfer Has A Data Problem, Not A Process Problem
Technology Transfer Has A Data Problem, Not A Process Problem
Forbes

Dr. Siva Samy is the founder and CEO of ValGenesis, an inventor with 8 patents in digital and AI-based validation, and a Ph.D in Pharma. ​Technology transfer is one of the most critical processes in life sciences manufacturing. It is also…

newswire.ca - Synthio Labs Launches DOSE Benchmark: Leading Voice AI Models Mispronounce Up to One in Three Newly Approved Drug Names
Synthio Labs Launches DOSE Benchmark: Leading Voice AI Models Mispronounce Up to One in Three Newly Approved Drug Names
CNW

Nine commercial text-to-speech systems tested on 274 medicines in clinical sentences; ElevenLabs, Google, Deepgram, Microsoft and OpenAI models drop sharply on recently approved drugs SAN FRANCISCO, Sept. 17, 2026 /CNW/ -- Synthio Labs, a…

globenewswire.com - F. Hoffmann-La Roche Ltd - Roche announces grand opening of its Innovation Center Boston to drive advancements in Cardiovascular, Renal and Metabolic diseases
Roche announces grand opening of its Innovation Center Boston to drive advancements in Cardiovascular, Renal and Metabolic diseases
GlobeNewswire

The center will be a hub for Roche and Genentech, bringing together expertise in Cardiovascular, Renal and Metabolism, as well as for data science and AI specialists to drive innovation in drug discovery and development It will expand Roche's and…

bbc.co.uk - Nikhil Inamdar - India's hospital boom is improving access but pricing millions out of critical care
India's hospital boom is improving access but pricing millions out of critical care
BBC

On a recent visit to Miraj, a small town in western India where I grew up, I counted more than 50 multi-specialty hospitals, diagnostics centres and health clinics packed along a five kilometre stretch of road. Many of them had come up in just the…

seekingalpha.com - Albert Anthony - Alkami Technology: A Modest Growth Idea Among Tech Stocks Serving Digital Banking (ALKT)
Alkami Technology: A Modest Growth Idea Among Tech Stocks Serving Digital Banking (ALKT)
Seeking Alpha

Albert Anthony is the pen name of a business author on Amazon and his newest book is 'How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,' now available as a 2026 edition paperback and Kindle ebook in several…

fool.com - Alex Carchidi - Where Will CRISPR Therapeutics Be in 10 Years if Gene Editing Fulfills Its Promise?
Where Will CRISPR Therapeutics Be in 10 Years if Gene Editing Fulfills Its Promise?
The Motley Fool

Technically sophisticated gene-editing biotechs like CRISPR Therapeutics (CRSP +9.80%) could become dramatically more capable over the next 10 years if their most ambitious plans come to fruition. If that happens, it'd likely make those who invest…

news-medical.net - Big Picture Bio founded to identify, design and optimize promising cancer combination therapies
Big Picture Bio founded to identify, design and optimize promising cancer combination therapies
News-Medical

Big Picture Bio Ltd., has been founded to identify, design and optimize promising cancer combination therapies, using a generative world model to understand how tumors, immune cells and surrounding tissue interact across disease sites and patient…

Receive a Daily briefing on Pharma Industry News

Get Started